Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8582 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8582 |
High Similarity |
NPD1613 |
Approved |
0.8571 |
High Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8489 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.844 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8429 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8429 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8201 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8121 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8112 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8099 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8058 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8041 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8041 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8028 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7945 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7887 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7829 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7812 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.777 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7763 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7707 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7681 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7674 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7643 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7628 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD37 |
Approved |
0.7616 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7593 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7593 |
Intermediate Similarity |
NPD4965 |
Approved |
0.759 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7569 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7544 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7544 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7544 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7544 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7544 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7544 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7533 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7533 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD8651 |
Approved |
0.75 |
Intermediate Similarity |
NPD7340 |
Approved |
0.75 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7467 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7455 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7423 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7384 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD27 |
Approved |
0.7381 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7365 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7356 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7347 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7342 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7321 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7321 |
Intermediate Similarity |
NPD2969 |
Approved |
0.731 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD7157 |
Approved |
0.729 |
Intermediate Similarity |
NPD5763 |
Approved |
0.729 |
Intermediate Similarity |
NPD5762 |
Approved |
0.729 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7261 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.725 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD8054 |
Approved |
0.72 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7192 |
Intermediate Similarity |
NPD3092 |
Approved |
0.719 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7184 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7168 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD228 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7122 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7122 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7095 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7081 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7075 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7048 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7044 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD3091 |
Approved |
0.703 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7027 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7025 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7005 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7005 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7 |
Intermediate Similarity |
NPD2677 |
Approved |
0.6994 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6993 |
Remote Similarity |
NPD7985 |
Registered |
0.6987 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6975 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6972 |
Remote Similarity |
NPD7843 |
Approved |
0.6968 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6959 |
Remote Similarity |
NPD6071 |
Discontinued |
0.6957 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6952 |
Remote Similarity |
NPD4004 |
Approved |
0.6952 |
Remote Similarity |
NPD4002 |
Approved |
0.6948 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD5588 |
Approved |
0.6943 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6937 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6935 |
Remote Similarity |
NPD3450 |
Approved |
0.6935 |
Remote Similarity |
NPD3452 |
Approved |
0.6933 |
Remote Similarity |
NPD6090 |
Discontinued |
0.6932 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6929 |
Remote Similarity |
NPD2684 |
Approved |
0.6928 |
Remote Similarity |
NPD7411 |
Suspended |
0.6918 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6918 |
Remote Similarity |
NPD7037 |
Approved |
0.6909 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6909 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD5736 |
Approved |
0.6906
|
Remote Similarity |
NPD2488 |
Approved |